India's Richest People 2026 edition · 1 director · Source: Hurun India
- #590 Inderjit Kaur & Family ₹5,700 Cr
Well Worth Medicines Private Limited
Well Worth Medicines Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Active Private Limited Company pharma
Revenue · FY 2025
₹15.75 Lakh
▼ 40% YoY
Net profit · FY 2025
₹3.17 Lakh
Net margin 20.1%
EBITDA · FY 2025
₹7.43 Lakh
EBITDA margin 47.1%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹74.73 Lakh
Issued & subscribed
Company age
37 yrs
Est. 1989
Directors on board
2
As per MCA filings
GST registrations
2
None active
About Well Worth Medicines Private Limited
Data last updated:
Well Worth Medicines Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 December 1989 and has been in existence for over 37 years.
Its director Inderjit Kaur and Family is #590 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1989PTC132889. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹74.73 Lakh. It is led by directors Inderjeet Kaur Bhupinder Singh and Harpreet Singh Bhupinder Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 107 – A Vinay Bhavya Complex 159 – A C.S.T. Road Kalina Santacruz, Mumbai, Maharashtra, India – 400098.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.75 Lakh, a decline of 40% compared to the previous year. For the same year it recorded a net profit of ₹3.17 Lakh (net margin 20.1%) and EBITDA of ₹7.43 Lakh (EBITDA margin 47.1%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230MH1989PTC132889
Registration Number 132889
Incorporation Date 01 December 1989
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
CIN history
Well Worth Medicines has one previous CIN (Corporate Identification Number): U99999MH2001PTC132889. The current CIN is U24230MH1989PTC132889, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1989PTC132889 | Current |
| U99999MH2001PTC132889 | Previous |
Recognitions & Rankings of Well Worth Medicines
Contact details
Well Worth Medicines Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address107 – A Vinay Bhavya Complex 159 – A C.S.T. Road Kalina Santacruz, Mumbai, Maharashtra, India – 400098
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Well Worth Medicines Private Limited, buy the company report.
Comprehensive company report
Well Worth Medicines Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Well Worth Medicines is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
Financials of Well Worth Medicines Private Limited
FY 2025 filings availableWell Worth Medicines Private Limited reported revenue of ₹15.75 Lakh (down 40% YoY) for FY 2025.
Revenue · FY 2025
₹15.75 Lakh ▼ 40%
Net profit · FY 2025
₹3.17 Lakh margin 20.1%
EBITDA · FY 2025
₹7.43 Lakh margin 47.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 40%
3 years · compounded
▼ 1%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 55%
3 years · compounded
▲ 10%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 40% fall in the latest year. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.43 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 47.1% | ||||
| Net Profit Margin | 20.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Well Worth Medicines Private Limited, buy the company report.
Board of directors of Well Worth Medicines Private Limited
Well Worth Medicines has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Inderjeet Kaur Bhupinder Singh Also directs: Harman Finochem Limited, Kirti Merchantile Private Limited, Shreefal Engineering Private Limited and 1 more | Director | 15 Jul 1996 | 30 Years 3 Months | Current |
| Harpreet Singh Bhupinder Singh Also directs: Harman Finochem Limited, Kirti Merchantile Private Limited, Shreefal Engineering Private Limited and 4 more | Director | 24 Aug 2001 | 25 Years 2 Months | Current |
Auditor
Well Worth Medicines Private Limited is audited by K. U. Kothari & Co for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K. U. Kothari & Co | FY 2016 |
Shareholding
The shareholding of Well Worth Medicines Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Well Worth Medicines Private Limited, buy the company report.
Legal cases
Well Worth Medicines Private Limited has 3 court cases on record: 2 filed by Well Worth Medicines, 1 filed against it. All cases are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Interim or miscellaneous application | Filed against the company by Medizest Pharmaceuticals Private Limited | Disposed |
| District court, Valsad, Gujarat | Court case (SPCS) | Filed by the company against Kare Labs Private Limited | Disposed |
| District court, Valsad, Gujarat | Court case (SPCS) | Filed by the company against Kare Labs Private Limited | Disposed |
To see the full case history of Well Worth Medicines Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Well Worth Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Well Worth Medicines has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
Total GSTINs
2
Cancelled / inactive
2
To see the full GST registrations and return filing status of Well Worth Medicines Private Limited, buy the company report.
Recent activity
Well Worth Medicines Private Limited has 3 board changes on record since 1996: 2 appointments and 1 cessation. The latest: Bhupinder Singh Jagdevsingh Manhas ceased to be Director on 09 Oct 2023.
AGM
Well Worth Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Well Worth Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Bhupinder Singh Jagdevsingh Manhas ceased to be Director.
Appointed
Harpreet Singh Bhupinder Singh was appointed as Director.
Appointed
Inderjeet Kaur Bhupinder Singh was appointed as Director.
Incorporation
01 Dec 1989
Well Worth Medicines Private Limited was registered on 01 Dec 1989 with Roc Mumbai & aged 36 years 11 months as per MCA records.
Frequently asked questions
Well Worth Medicines is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 December 1989 (37+ years old) and is registered under CIN U24230MH1989PTC132889.
Well Worth Medicines has 2 current directors:
- Inderjeet Kaur Bhupinder Singh - Director
- Harpreet Singh Bhupinder Singh - Director
The latest financial statements of Well Worth Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Well Worth Medicines has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Well Worth Medicines is U24230MH1989PTC132889. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Well Worth Medicines has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the district courts.
Well Worth Medicines was incorporated on 01 December 1989, making it 37+ years old. It is registered with the Registrar of Companies, Mumbai.
Bhupinder Singh Jagdevsingh Manhas ceased to be Director on 09 Oct 2023. Harpreet Singh Bhupinder Singh was appointed as Director on 24 Aug 2001. Inderjeet Kaur Bhupinder Singh was appointed as Director on 15 Jul 1996.
The registered office of Well Worth Medicines is at 107 – A Vinay Bhavya Complex 159 – A C.S.T. Road Kalina Santacruz, Mumbai, Maharashtra, India – 400098.
Well Worth Medicines operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages